Larvol Delta - Phase-II-Study-of-Firstline-Amrubicin-in-Elderly-Patients-with-Extensive-Disease-SmallCell-Lung-Cancer-CJLSG1104

Calsed (amrubicin) - BMS

http://clinicaltrials.gov/ct2/show/UMIN000009548

Sep 25, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next